Since I last owned them, they have grown their malpractice insurance business nicely. Their brokerage arm for doctor clients took a hit in the market crash but that should come back over time. Looks like this one has the potential to generate earnings to warrant a $30 share price somewhere down the line.

Very sleepy and illiquid stock so no one should buy it with any expectation it will be zoom next week.